Sign in
Enrolling by invitationNo phase

Effects of Lactic Acid Bacteria in Patients With Attention-Deficit/Hyperactivity Disorder

Key facts

Who runs it
I-Ching Chou
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Enrolling by invitation
People taking part
80 people, planned
Started
25 Feb 2026
Expected to end
31 Dec 2028
Type of study
Interventional
Treatments tested
  • postbiotics
Record updated
27 February 2026

Who can take part

Age
6 years to 13 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Age 6-13 years old
  • Has been diagnosed with ADHD and is taking medication regularly or has not yet started medication

Who cannot take part

  • Have taken antibiotics within one month or are receiving antibiotic treatment
  • Those who are allergic to lactic acid bacteria products
  • Have used probiotic products in powder, capsule or tablet form within one month (including yogurt, yogurt, Yakult and other related foods)
  • Obtain a disability certificate
  • Participating in other human research
  • Determined unsuitable by the investigator

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 6 and 13 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The study aims to evaluate whether postbiotics supplementation can improve ADHD symptoms, such as mood and sleep, in children. Furthermore, salivary biochemical profiles will be analyzed and dietary habits will be recorded to further explore the effects and mechanisms of action of postbiotics.

Read full original descriptionShow less

Research process: 80 subjects who meet the admission conditions will be recruited within three years after IRB approval. They will take the research capsules (postbiotics) in an open label design study and complete the 8-week intervention plus 4 weeks follow up trial period.

The group in the trial

  • PostbioticsTreatment being tested

    Dietary Supplement

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT07419659, who can take part
Record updated
27 February 2026